What we heard: Agile regulations for advanced therapeutic products and clinical trials
The Health and Biosciences Sector Regulatory Review Roadmap outlined a number of regulatory modernization commitments. These included plans to modernize the regulations for clinical trials and advanced therapeutic products (ATPs).
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
What we heard: Agile regulations for advanced therapeutic products and clinical trialsHTMLEnglish publication HTML
-
What we heard: Agile regulations for advanced therapeutic products and clinical trialsHTMLFrench publication HTML
Similar records